Alexis Pinto is Chief Legal Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 22,240 shares of ZNTL, which is worth approximately $71,835. The most recent transaction as insider was on Feb 14, 2022, when has been sold 691 shares (Common Stock) at a price of $50.46 per share, resulting in proceeds of $34,868. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.2K
0% 3M change
0% 12M change
Total Value Held $71,835

Alexis Pinto Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2022
SELL
Open market or private sale
$34,868 $50.46 p/Share
691 Reduced 3.01%
22,240 Common Stock
Feb 10 2022
BUY
Grant, award, or other acquisition
-
16,405 Added 41.7%
22,931 Common Stock
Oct 25 2021
SELL
Open market or private sale
$2,327,100 $77.57 p/Share
30,000 Reduced 82.13%
6,526 Common Stock
Oct 25 2021
BUY
Exercise of conversion of derivative security
$1,032,000 $34.4 p/Share
30,000 Added 45.1%
36,526 Common Stock
Feb 11 2021
BUY
Grant, award, or other acquisition
-
6,250 Added 50.0%
6,250 Common Stock
AP

Alexis Pinto

Chief Legal Officer
New York, NY

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Track Activities on ZNTL